Acute Cognition and Exercise
ACE
Acute Exercise and Cognitive Function: Examining the Role of Weight Status and Exercise-Induced Myokines
1 other identifier
interventional
26
1 country
1
Brief Summary
The central hypothesis is that, while both groups will benefit from the exercise session, participants with obesity will exhibit greater gains in cognitive control, relative to healthy weight adults. Additionally, it is anticipated that the benefits of a single bout of exercise for cognitive control will be mediated by changes in exercise-induced myokines. These hypotheses will be tested by accomplishing three aims: Aim 1: Elucidate the changes in cognitive control following an acute bout of exercise, relative to a sedentary condition, in persons with and without obesity. Aim 2: To examine the effect of a single bout of exercise, relative to a sedentary condition, on myokines known to have neuroprotective effects i.e., BDNF and CTSB in both healthy weight and individuals with obesity. Aim 3: To link changes in exercise-induced myokines (i.e., BDNF and CTSB) to changes in cognitive function, following a single bout of exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable obesity
Started Sep 2021
Shorter than P25 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 2, 2021
CompletedFirst Submitted
Initial submission to the registry
October 1, 2021
CompletedFirst Posted
Study publicly available on registry
October 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 28, 2022
CompletedFebruary 20, 2024
February 1, 2024
8 months
October 1, 2021
February 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Circulating Cathepsin B (CTSB) Myokine
Changes in peripheral myokine concentration
3 hours
Attentional Inhibition Accuracy
Behavioral performance measured as accuracy (%) during Flanker task
3 hours
Attentional Inhibition Reaction Time
Behavioral performance measured as response time (ms) during Flanker task
3 hours
Attentional Resource Allocation
Changes in P3 event related potential amplitude (microvolts) using a computerized flanker task
3 hours
Attentional Processing Speed
Changes in P3 event related potential latency (ms) using a computerized flanker task
3 hours
Relational Memory
Accuracy during a spatial reconstruction task
3 hours
Secondary Outcomes (1)
Brain derived neurotrophic factor (BDNF)
3 hours
Study Arms (2)
Exercise
EXPERIMENTAL36 minutes of exercise
Rest
PLACEBO COMPARATOR36 minutes of rest
Interventions
Eligibility Criteria
You may qualify if:
- Between ages 18 and 35
- No prior diagnosis of neurological disorders (e.g., autism spectrum disorder)
- No prior diagnosis of metabolic disease (e.g., diabetes, cardiovascular disease)
- No physical disability that would preclude the participant from completing a VO2max test
- Corrected vision (based on the minimal 20/20 standard needed to complete cognitive tasks)
- Not pregnant
- BMI between 18.5 and 25.0 kg/m2, or BMI greater than 30.0 kg/m2
- Readiness for exercise (determined through PAR-Q)
You may not qualify if:
- \<18 years and \>35 years
- Diagnosis of neurological disorders (e.g., autism spectrum disorder)
- Diagnosis of metabolic disease (e.g., diabetes, cardiovascular disease)
- Physical disability that would preclude the participant from completing a VO2max test
- Lack of corrected vision (based on the minimal 20/20 standard needed to complete cognitive tasks)
- Pregnancy
- BMI less than 18.5 kg/m2 or BMI greater than 25.0 but less than 30.0 kg/m2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Illinois at Urbana-Champaign
Urbana, Illinois, 61801, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 1, 2021
First Posted
October 14, 2021
Study Start
September 2, 2021
Primary Completion
April 28, 2022
Study Completion
April 28, 2022
Last Updated
February 20, 2024
Record last verified: 2024-02